Dr. Agarwal’s Health Care Limited announced strong unaudited consolidated financial results. Total income for Q3 FY2026 reached INR 540 Crores, reflecting a 21.9% YoY growth. The company’s network has expanded to 272 facilities across 10 countries. The results highlight robust growth in revenues and profitability. The company also shifts its registered office in Chennai to facilitate better administrative convenience and infrastructure requirements.
Financial Performance Highlights
Dr. Agarwal’s Health Care Limited reported significant growth for Q3 FY2026:
- Total Income: Increased by 21.9% YoY to INR 540 Crores.
- EBITDA: Grew by 21.3% YoY.
- Profit After Tax: Increased by 54.5% YoY.
Key Operational Metrics
The company showcased robust operational performance metrics:
- Surgeries performed in Q3 FY2026: 81,002, a growth of 11.2% YoY.
- Network Expansion: Reached 272 facilities, with 14 new centers added during the quarter.
Strategic Developments
Dr. Agarwal’s Health Care Limited is undertaking key strategic initiatives:
- Ethiopian Subsidiary: Incorporating a wholly-owned subsidiary in Ethiopia.
- Registered Office: Shifting the registered office to a new location in Chennai.
- Associate Company: Idearx ceases to be an associate company.
Comments from Leadership
Dr. Adil Agarwal, CEO, stated that the company delivered a strong performance in Q3 FY26, driven by robust growth, healthy patient volumes, and improved contribution from newer facilities. He also noted the expansion of the network and the company’s focus on sustainable growth and patient care.
Source: BSE
